Enhabit, Inc. (NYSE:EHAB) Given Consensus Recommendation of “Hold” by Brokerages

Enhabit, Inc. (NYSE:EHAB) has earned an average rating of “Hold” from the six analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $8.75.

Several equities research analysts have issued reports on the stock. Jefferies Financial Group raised shares of Enhabit from a “hold” rating to a “buy” rating and raised their price target for the stock from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners reissued a “market perform” rating and set a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th.

Insiders Place Their Bets

In other news, Director Stuart M. Mcguigan purchased 15,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was bought at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the purchase, the director now directly owns 46,810 shares of the company’s stock, valued at $412,396.10. The trade was a 47.15 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeffrey Bolton acquired 4,000 shares of Enhabit stock in a transaction dated Thursday, December 12th. The stock was purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the completion of the purchase, the director now directly owns 98,144 shares in the company, valued at approximately $852,871.36. This represents a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is owned by corporate insiders.

Institutional Trading of Enhabit

A number of institutional investors and hedge funds have recently bought and sold shares of EHAB. Jane Street Group LLC lifted its position in Enhabit by 514.3% during the third quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock valued at $7,119,000 after buying an additional 754,395 shares in the last quarter. Marshall Wace LLP purchased a new position in shares of Enhabit in the 2nd quarter valued at $1,941,000. Paradice Investment Management LLC lifted its holdings in shares of Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock valued at $13,903,000 after acquiring an additional 201,997 shares in the last quarter. Systematic Financial Management LP boosted its position in Enhabit by 12.2% during the 3rd quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after purchasing an additional 199,235 shares during the period. Finally, Bardin Hill Management Partners LP increased its holdings in Enhabit by 927.4% in the 3rd quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock valued at $1,377,000 after purchasing an additional 157,338 shares in the last quarter.

Enhabit Price Performance

EHAB stock opened at $8.24 on Friday. The stock’s 50 day moving average price is $8.04 and its 200 day moving average price is $8.04. The firm has a market cap of $414.21 million, a P/E ratio of -3.55 and a beta of 1.83. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74.

Enhabit (NYSE:EHAB) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The company had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. During the same period in the previous year, the business earned $0.03 EPS. On average, sell-side analysts expect that Enhabit will post 0.22 earnings per share for the current fiscal year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.